Nyxoah S.A. (NASDAQ:NYXH – Get Rating) – Cantor Fitzgerald dropped their FY2022 earnings estimates for Nyxoah in a report released on Tuesday, March 29th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings per share of ($1.71) for the year, down from their prior estimate of ($1.54). Cantor Fitzgerald currently has […]
Zacks Investment Research cut shares of Nyxoah (NASDAQ:NYXH – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, “Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. […]
Nyxoah (NASDAQ:NYXH) Lifted to Hold at Zacks Investment Research etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.